Cell cycle oscillators underlying orderly proteolysis of E2F8.


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
01 04 2020
Historique:
pubmed: 30 1 2020
medline: 3 6 2021
entrez: 30 1 2020
Statut: ppublish

Résumé

E2F8 is a transcriptional repressor that antagonizes E2F1 at the crossroads of the cell cycle, apoptosis, and cancer. Previously, we discovered that E2F8 is a direct target of the APC/C ubiquitin ligase. Nevertheless, it remains unknown how E2F8 is dynamically controlled throughout the entirety of the cell cycle. Here, using newly developed human cell-free systems that recapitulate distinct inter-mitotic and G1 phases and a continuous transition from prometaphase to G1, we reveal an interlocking dephosphorylation switch coordinating E2F8 degradation with mitotic exit and the activation of APC/C

Identifiants

pubmed: 31995441
doi: 10.1091/mbc.E19-12-0725
pmc: PMC7185961
doi:

Substances chimiques

ANAPC1 protein, human 0
Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome 0
CCNF protein, human 0
Cyclins 0
E2F1 Transcription Factor 0
E2F1 protein, human 0
E2F8 protein, human 0
Recombinant Proteins 0
Repressor Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

725-740

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120309
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007040
Pays : United States

Références

J Cell Sci. 2017 Aug 15;130(16):2673-2681
pubmed: 28663385
Cell. 1995 Apr 21;81(2):279-88
pubmed: 7736580
Trends Cell Biol. 2009 Mar;19(3):111-8
pubmed: 19201609
Nat Rev Mol Cell Biol. 2011 Jul 13;12(8):469-82
pubmed: 21750572
Nucleic Acids Res. 2005 Sep 22;33(17):5458-70
pubmed: 16179649
Genes Dev. 2000 Mar 15;14(6):655-65
pubmed: 10733526
Nature. 1989 May 25;339(6222):275-80
pubmed: 2566917
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1355-60
pubmed: 20080579
EMBO J. 2003 Dec 1;22(23):6289-98
pubmed: 14633988
Cell Rep. 2018 May 29;23(9):2758-2769
pubmed: 29847804
Angew Chem Int Ed Engl. 2013 Jan 2;52(1):192-8
pubmed: 23124625
Science. 1999 Jul 16;285(5426):418-22
pubmed: 10411507
PLoS One. 2013;8(2):e57532
pubmed: 23469016
Dev Cell. 2008 Jan;14(1):62-75
pubmed: 18194653
J Cell Biol. 2012 Jun 25;197(7):887-95
pubmed: 22711698
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12327-32
pubmed: 8901580
EMBO J. 2002 Sep 2;21(17):4500-10
pubmed: 12198152
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70
pubmed: 21307310
Cell Cycle. 2009 Feb 15;8(4):532-5
pubmed: 19182518
EMBO J. 2019 Oct 15;38(20):e101430
pubmed: 31475738
Mol Cell. 2019 Jun 20;74(6):1264-1277.e7
pubmed: 31130363
Mol Biol Cell. 1995 Feb;6(2):185-97
pubmed: 7787245
Genes Dev. 2010 Jul 1;24(13):1364-76
pubmed: 20551165
Cell Rep. 2018 Sep 25;24(13):3404-3412
pubmed: 30257202
Exp Cell Res. 2000 Mar 15;255(2):184-91
pubmed: 10694434
Cell. 2006 Jan 13;124(1):89-103
pubmed: 16413484
Cell Rep. 2016 Sep 20;16(12):3359-3372
pubmed: 27653696
Biochim Biophys Acta Mol Cell Res. 2018 Dec;1865(12):1924-1933
pubmed: 30290241
Science. 2014 Oct 10;346(6206):244-7
pubmed: 25301629
Cell. 1998 Jun 12;93(6):1043-53
pubmed: 9635433
EMBO J. 2000 Jun 1;19(11):2580-91
pubmed: 10835356
Methods Mol Biol. 2016;1342:71-88
pubmed: 26254918
J Cell Biol. 1997 Jul 28;138(2):385-93
pubmed: 9230080
Nature. 1998 Dec 10;396(6711):590-4
pubmed: 9859996
Genes Dev. 1994 Jul 1;8(13):1514-25
pubmed: 7958836
Science. 1998 Nov 27;282(5394):1721-4
pubmed: 9831566
Mol Cell Proteomics. 2015 Oct;14(10):2824-32
pubmed: 26276765
Semin Cell Dev Biol. 2011 Aug;22(6):544-50
pubmed: 21477659
Int J Biochem Cell Biol. 2017 Aug;89:216-220
pubmed: 28652210
Nature. 2010 Jul 1;466(7302):138-42
pubmed: 20596027
Cell Cycle. 2013 Sep 15;12(18):2992-3000
pubmed: 23974109
J Cell Biol. 2002 Jun 24;157(7):1125-37
pubmed: 12070128
Nat Rev Cancer. 2009 Nov;9(11):785-97
pubmed: 19851314
Cell. 2000 Aug 18;102(4):411-24
pubmed: 10966104
Nat Cell Biol. 1999 Aug;1(4):193-9
pubmed: 10559916
Trends Biochem Sci. 2012 Feb;37(2):66-73
pubmed: 22099186
Cell. 2008 May 16;133(4):653-65
pubmed: 18485873
Cell Cycle. 2012 May 15;11(10):2030-8
pubmed: 22580462
EMBO J. 2001 Feb 15;20(4):792-801
pubmed: 11179223
Dev Cell. 2012 Apr 17;22(4):849-62
pubmed: 22516201
EMBO Rep. 2016 Mar;17(3):414-27
pubmed: 26882548
Nature. 2015 Jan 1;517(7532):94-98
pubmed: 25487150
J Biol Chem. 2005 May 6;280(18):18211-20
pubmed: 15722552
Methods Enzymol. 2005;399:404-14
pubmed: 16338372
Nature. 2008 Jul 17;454(7202):353-7
pubmed: 18552837
EMBO J. 2019 Oct 15;38(20):e101443
pubmed: 31424118
EMBO Rep. 2008 Mar;9(3):252-9
pubmed: 18202719
Trends Cell Biol. 2019 Feb;29(2):117-134
pubmed: 30482618
Mol Biol Cell. 2000 May;11(5):1555-69
pubmed: 10793135
J Cell Biol. 2001 Jul 9;154(1):85-94
pubmed: 11448992
Curr Biol. 1999 Mar 11;9(5):227-36
pubmed: 10074450
Trends Cell Biol. 2013 Mar;23(3):135-40
pubmed: 23182110
Cell. 2003 Apr 4;113(1):101-13
pubmed: 12679038
J Biol Chem. 2013 Aug 23;288(34):24581-9
pubmed: 23853115
Mol Biol Cell. 2020 Apr 1;31(8):725-740
pubmed: 31995441
Trends Cell Biol. 2008 Nov;18(11):528-35
pubmed: 18805009
J Biol Chem. 2003 Oct 24;278(43):42041-9
pubmed: 12893818
PLoS One. 2013 Dec 31;8(12):e83935
pubmed: 24391848
Nature. 2004 Dec 2;432(7017):588-95
pubmed: 15558010
EMBO J. 2014 Feb 18;33(4):385-99
pubmed: 24510915

Auteurs

Danit Wasserman (D)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Sapir Nachum (S)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Meital Cohen (M)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Taylor P Enrico (TP)

Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

Meirav Noach-Hirsh (M)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Jasmin Parasol (J)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Sarit Zomer-Polak (S)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Naomi Auerbach (N)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Evelin Sheinberger-Chorni (E)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Hadas Nevenzal (H)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Nofar Levi-Dadon (N)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Xianxi Wang (X)

Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

Roxane Lahmi (R)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Efrat Michaely (E)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Doron Gerber (D)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Michael J Emanuele (MJ)

Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.

Amit Tzur (A)

Faculty of Life Sciences and Institute of Nanotechnology and Advanced Materials, Bar-llan University, Ramat-Gan 5290002, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH